Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialtypharmaceutical and drug delivery company, today announced it will hosta conference call to discuss its fourth quarter and full year 2005financial results on Thursday, March 9, 2006 at 10:00 a.m. EasternStandard Time. The call will follow the release of these financialresults on Wednesday, March 8, 2006, after the closing of the market.
To listen to the conference call, please dial 866-425-6192 (UnitedStates and Canada) or 973-935-2981 (International). The access codefor the call is 7097569. Please dial in approximately 10 minutesbefore the start of the conference call. You can access a live webcastof this conference on the Company's web site at www.bentleypharm.com.The webcast will be archived for 90 days.
A playback of the call will be available from approximately 1:00p.m. Eastern Standard Time on March 9, 2006 through March 16, 2006.You can access the playback at 877-519-4471 (United States and Canada)or 973-341-3080 (International). Please reference reservation number7097569.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceuticalcompany focused on advanced drug delivery technologies andpharmaceutical products. Bentley's proprietary drug technologiesenhance or facilitate the absorption of pharmaceutical compoundsacross various membranes. Bentley also manufactures a growingportfolio of generic and branded pharmaceuticals in Europe for thetreatment of cardiovascular, gastrointestinal, infectious andneurological diseases through its subsidiary, Laboratorios Belmac, andmarkets these pharmaceutical products through its subsidiaries,Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar andBentley Pharmaceuticals Ireland; and manufactures and markets activepharmaceutical ingredients through its subsidiary, Bentley API.
Copies of Bentley Pharmaceuticals' press releases and otherinformation may be obtained through Bentley's web site atwww.bentleypharm.com.
